Plasma glucose is not associated with performance on standard cognitive screening tests in a mixed memory clinic cohort—An observational cross‐sectional study

Abstract

AbstractBackgroundIt has been shown under experimental conditions that cognitive performance, especially working memory, is impaired in patients with type I and type II diabetes mellitus during hyperglycemic and hypoglycemic conditions, perhaps due to altered cerebral glucose metabolism. It is not known if patients with neurodegenerative diseases, who also exhibit pathological cerebral glucose metabolism, are affected in a similar manner by their plasma glucose levels.ObjectiveWe aimed to test if performance on two cognitive screening tests was associated with plasma glucose levels in a memory clinic cohort.MethodsWe included patients from the Copenhagen Memory Clinic Cohort with an available Mini Mental‐State Examination (MMSE) test score and a plasma glucose measurement performed in conjunction with cognitive testing. We built linear regression models with MMSE and Addenbrooke's Cognitive Examination (ACE) test scores as the outcome and plasma glucose as the explaining variable and adjusted models for age, sex, and diabetes (plasma glucose measurement >11.1 mmol/L). We explored non‐linear relationships by adding quadratic terms and by fitting a cubic spline regression model.ResultsIn total, 2714 patients had an available MMSE score and a plasma glucose measurement. MMSE and ACE total scores were not associated with plasma glucose in a linear or non‐linear fashion when we adjusted for age, sex, and diabetes.ConclusionPlasma glucose levels, predominantly within normal ranges, were not associated with performance on routinely applied cognitive tests and do not need to be taken into consideration when interpreting test results from memory clinic patients.